When should we start enzyme replacement therapy for infantile Pompe disease with severe cardiomyopathy?

Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):100-2. doi: 10.1016/j.recesp.2011.03.025. Epub 2011 Jun 28.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiomyopathies / drug therapy*
  • Cardiomyopathies / etiology
  • Echocardiography
  • Electrocardiography
  • Enzyme Replacement Therapy / methods*
  • Female
  • Glycogen Storage Disease Type II / complications
  • Glycogen Storage Disease Type II / diagnostic imaging
  • Glycogen Storage Disease Type II / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prognosis
  • Radiography
  • alpha-Glucosidases / therapeutic use

Substances

  • alpha-Glucosidases